NGM·Healthcare·$242M·#78 / 520 in Healthcare
ADAG Adagene Inc.
67SOLID
CATEGORY BREAKDOWN
GROWTH100
QUALITY40
STABILITY95
VALUATION0
GOVERNANCE56
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+7332.8%
100
> 50% strong
Gross Margin
Revenue retained after direct costs
N/A
0
> 50% strong
Cash Runway
Months of cash at current burn rate
57 months
100
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
17.7%
86
< 25% strong
Price / Sales
Market cap relative to trailing revenue
31.5x
0
< 3x strong
Rule of 40
Growth rate plus operating margin
7053
100
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
11.1%
67
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+12.2%
33
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE ADAG WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when ADAG's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.